Virological responses to lamivudine or emtricitabine when combined with tenofovir and a protease inhibitor in treatment-naive HIV-1-infected patients in the Dutch AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort

The ATHENA National ObservationalCohort Study, Astrid Oude Lashof, Selwyn Lowe, Dirk Posthouwer

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)571-580
Number of pages10
JournalHIV Medicine
Volume17
Issue number8
DOIs
Publication statusPublished - Sep 2016

Keywords

  • HIV-1
  • antiretroviral therapy
  • boosted protease inhibitors
  • emtricitabine
  • lamivudine
  • ANTIRETROVIRAL-NAIVE
  • ABACAVIR-LAMIVUDINE
  • ONCE-DAILY DOLUTEGRAVIR
  • SUPPRESSED PATIENTS
  • REVERSE-TRANSCRIPTASE
  • INITIAL TREATMENT
  • RESISTANCE PROFILES
  • MULTICENTER TRIAL
  • CONTAINING REGIMENS
  • HIV-1 INFECTION

Cite this